This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,921.41 firm fixed-price delivery order is for the supply of Spiriva Respimat 2.5 mcg inhalation medication, with a completion date of December 19, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a task order issued under that larger IDC. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying essential medical products to various federal agencies, particularly the DLA, which supports the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/19/25, 9:50 AM